← Back to Search

Enhancing Cancer Pain Management for Other Cancers

N/A
Waitlist Available
Led By Lara Traeger, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial is to see how effective a certain type of medication is for cancer patients with chronic pain, and to improve the management of said pain.

Eligible Conditions
  • Other Cancers

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants who complete study sessions
Number of participants who identify study components as acceptable

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Enhancing Cancer Pain Management Part 2Experimental Treatment1 Intervention
Enhancing Cancer Pain Management will consist of 3 individual manualized sessions The 3 individual manualized sessions will be conducted (approximately 20 minutes each), led by a nurse practitioner, to provide sufficient dose for change in adherence behaviors. Learning and practicing skills for managing cancer-related pain and adhering to prescribed LA opioid regimens. Study staff will provide participants with MEMS caps and bottles at time of enrollment, to monitor LA opioid intake over approximately 14 weeks.
Group II: Enhancing Cancer Pain Management Part 1Active Control1 Intervention
Will collect information from participants via self-report assessment at two time points: at baseline (i.e. study enrollment) and approximately 8 weeks post-baseline Will then use MEMS to monitor LA opioid intake over approximately 8 weeks A subset of enrolled participants (n=20) will be invited to participate in an optional one-time qualitative exit interview with a study staff member trained in conducting qualitative interviews

Find a Location

Who is running the clinical trial?

American Cancer Society, Inc.OTHER
224 Previous Clinical Trials
110,307 Total Patients Enrolled
1 Trials studying Other Cancers
53 Patients Enrolled for Other Cancers
Massachusetts General HospitalLead Sponsor
2,925 Previous Clinical Trials
13,197,754 Total Patients Enrolled
4 Trials studying Other Cancers
30,201 Patients Enrolled for Other Cancers
Lara Traeger, MDPrincipal InvestigatorMassachusetts General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Development of an Intervention to Enhance Cancer Pain Management
Lara Traeger 2014. "Development of an Intervention to Enhance Cancer Pain Management". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03752268.
~14 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top